2022
A Population-Level Analysis of the Protective Effects of Androgen Deprivation Therapy Against COVID-19 Disease Incidence and Severity
Lee KM, Heberer K, Gao A, Becker DJ, Loeb S, Makarov DV, Gulanski B, DuVall SL, Aslan M, Lee J, Shih MC, Lynch JA, Hauger RL, Rettig M. A Population-Level Analysis of the Protective Effects of Androgen Deprivation Therapy Against COVID-19 Disease Incidence and Severity. Frontiers In Medicine 2022, 9: 774773. PMID: 35602518, PMCID: PMC9115469, DOI: 10.3389/fmed.2022.774773.Peer-Reviewed Original ResearchAndrogen deprivation therapyCOVID-19 outcomesSARS-CoV-2ADT patientsDeprivation therapyCancer patientsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testingMale veteransSevere COVID-19 outcomesMultivariable logistic regression modelingSARS-CoV-2 infectionSevere COVID-19 illnessCOVID-19 pathophysiologyCOVID-19 patientsCOVID-19 illnessCOVID-19 severityVeterans Health AdministrationCoronavirus disease-19Logistic regression analysisLogistic regression modelingCOVID-19COVID-19 incidenceMale patientsCOVID-19 disease incidenceDisease-19
2005
Association between Impaired Insulin Sensitivity and Stroke
Bravata DM, Wells CK, Kernan WN, Concato J, Brass LM, Gulanski BI. Association between Impaired Insulin Sensitivity and Stroke. Neuroepidemiology 2005, 25: 69-74. PMID: 15947493, DOI: 10.1159/000086286.Peer-Reviewed Original ResearchConceptsHomeostasis model assessmentInsulin sensitivityGlycemic controlMultivariable logistic regression analysisStroke risk factorsLower insulin sensitivityThird National HealthImpaired insulin sensitivityLogistic regression analysisStroke historyInsulin resistancePlasma insulinPlasma glucoseRisk factorsNational HealthNutrition SurveyModel assessmentStrokeRegression analysisAssociationParticipantsClaudicationInsulin
2003
Association of Endogenous Sex Hormones and Insulin Resistance among Postmenopausal Women: Results from the Postmenopausal Estrogen/Progestin Intervention Trial
Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI. Association of Endogenous Sex Hormones and Insulin Resistance among Postmenopausal Women: Results from the Postmenopausal Estrogen/Progestin Intervention Trial. The Journal Of Clinical Endocrinology & Metabolism 2003, 88: 1646-1652. PMID: 12679451, DOI: 10.1210/jc.2002-021375.Peer-Reviewed Original ResearchMeSH KeywordsAdipose TissueAgedBiological AvailabilityBody CompositionBody ConstitutionBody Mass IndexEstradiolEstrogen Replacement TherapyFemaleGonadal Steroid HormonesHomeostasisHumansInsulin ResistanceLogistic ModelsMiddle AgedPostmenopauseProgestinsSex Hormone-Binding GlobulinTestosteroneVisceraConceptsBody mass indexInsulin resistanceBioavailable testosteroneBioavailable estradiolPostmenopausal womenTotal estradiolMass indexSex hormonesPostmenopausal Estrogen/Progestin Interventions (PEPI) TrialHomeostasis model assessment-IRLower SHBG levelsYounger postmenopausal womenYr of menopauseHomeostasis model assessmentHormone replacement therapyEndogenous sex hormonesModel assessment-IRDose-response fashionCross-sectional associationsLogistic regression analysisSHBG levelsTotal testosteroneVisceral adiposityHighest quartileTotal adiposity